Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels
about
Selective androgen receptor modulators in preclinical and clinical developmentTamoxifen: catalyst for the change to targeted therapyFourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancerEndocrinology and hormone therapy in breast cancer: endocrine therapy in premenopausal womenCurrent Medical Treatment of Patients with Non-Colorectal Liver Metastases: Primary Tumor Breast CancerThe discovery and development of selective estrogen receptor modulators (SERMs) for clinical practiceInfluence of anti-oestrogens on the specific binding in vitro of (3H)oestradiol by cytosol of rat mammary tumours and human breast carcinomataA model of estrogen-related gene expression reveals non-linear effects in transcriptional response to tamoxifen.A note from history: Landmarks in history of cancer, part 7.Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.In search of novel drug target sites on estrogen receptors using RNA aptamers.Tamoxifen as the first targeted long-term adjuvant therapy for breast cancerNew hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosis.Phosphorylation of androgen receptors at serine 515 is a potential prognostic marker for triple negative breast cancerCurrent and future directions in medical therapy for breast carcinoma: endocrine treatment.Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.Adjuvant therapy for renal cell carcinoma: past, present, and futureTamoxifen in the management of metastatic cancer of the breastTamoxifen: a most unlikely pioneering medicine.Manganese superoxide dismutase: beyond life and deathThe evolution of nonsteroidal antiestrogens to become selective estrogen receptor modulatorsTracking progesterone receptor-mediated actions in breast cancerTamoxifen and liver damageThe IGF pathway regulates ERα through a S6K1-dependent mechanism in breast cancer cells.Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.Linking estrogen-induced apoptosis with decreases in mortality following long-term adjuvant tamoxifen therapy.Anti-Proliferative Effects of Evodiamine on Human Breast Cancer Cells.Proven value of translational research with appropriate animal models to advance breast cancer treatment and save lives: the tamoxifen tale.Antiestrogen therapy in recurrent ovarian cancer resulting in 28 months of stable disease: a case report and review of the literatureCancer of the breast: forward look in the 1970s. Endocrine therapy-the future.Genotype-guided tamoxifen dosing increases active metabolite exposure in women with reduced CYP2D6 metabolism: a multicenter study.Progestins in breast cancer treatment. A review.A comparison of two doses of tamoxifen (Nolvadex) in postmenopausal women with advanced breast cancer: 10 mg bd versus 20 mg bd.Tamoxifen, aminoglutethimide and danazol: effect of therapy on hormones in post-menopausal patients with breast cancer.The Dual Estrogen Receptor α Inhibitory Effects of the Tissue-Selective Estrogen Complex for Endometrial and Breast Safety.Estrogen-responsive genes encoding egg yolk proteins vitellogenin and apolipoprotein II in chicken are differentially regulated by selective estrogen receptor modulators.Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer.New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.Selective estrogen receptor modulators and phytoestrogens.New generation of breast cancer clinical trials implementing molecular profiling.
P2860
Q24645579-658D3352-3D90-4447-8125-4421C6C87947Q24652988-2BE2EB95-7A87-4359-B323-FE66B4C6D2AAQ24685693-77EBD3E3-8E6C-4B98-8157-E3F32D4B5119Q24797219-C9C2A53F-A0A3-46D0-B86E-10062E8190CEQ26764987-2CB81049-318E-4B09-A744-EDBACF028DE1Q26830744-6DF05501-26AE-4773-8FC4-D3873B1AFD43Q28320433-1FB64540-5CF5-400C-B66F-046D89F79489Q30535835-6468B34D-50EB-4B38-B0D1-AE8031598660Q30931923-CCF8188A-843C-4AF9-9A49-C79F7008AC51Q33410375-BD092494-C798-4C44-B590-284E7B81EBD9Q33632085-06D4C84E-AF0D-43AF-B757-35A3664C15C7Q33642104-90ED745E-24AD-48DD-BC01-728D9FDD9A52Q33841512-AB76AD22-6E77-4237-8645-E7479FEDF718Q33913872-FEC39B2C-2639-4804-AB74-3505552DAE3AQ33970582-60B37096-46D1-407A-A057-8057AD1A5CC4Q34000409-9012CAA6-FAA2-42B9-9DFD-A8BED9011100Q34005127-FADC2274-3DE3-4E5E-9669-FA83AF52885DQ34107609-12A4BF4E-BD97-448A-8CFB-98A66BEB45CCQ34180688-928BD4C1-217D-48AA-97EF-F9B117B9EAF5Q34284548-742ADB68-E24D-4D60-A4A8-385D17315AFFQ34315816-40B9479E-989D-420A-B59B-ED6D7551B271Q34388848-A3D89DBE-15FD-438A-93AC-1E43DFF290E3Q34550698-B857C37A-EADE-4BC7-B8B9-45840238D1C0Q34609956-10FC0FF2-5743-431F-89BA-5F0F70DE8325Q34652138-1D074162-FA89-4556-B82C-577D256DF639Q34736075-DBD4FD7C-5D39-4883-AE56-44D733CA727CQ34806990-594ACE45-5CF6-44C0-9A39-11B0C8366360Q35023715-C80BC367-C3B4-4094-91FB-3D8BBE6C3356Q35138497-769CC2FE-CE3B-4449-ABBA-904BEB8463C2Q35144792-2300F71D-2EF6-4A18-967E-7D64D5720719Q35172199-9CE0AC4F-E2EE-4EF5-90EF-64E66A021B84Q35651439-617E38BA-0E92-43C4-B40B-0B9E995486A9Q35991734-8BA93CD4-1019-4654-8A58-10929C79CAE9Q36046662-624F86B8-858A-4991-ABA6-F9376C28C784Q36432425-AFF8B9C9-128F-4A59-BF93-ACE055E679B0Q36437107-7FC23C5B-1A36-430B-B85F-F4B0A35164CBQ36466862-8CBC96E1-C910-4BFF-B932-968FD3023C72Q36927087-70A641D3-DC31-4A31-A88A-8A8F3E855F52Q36984515-0B299E5E-D879-4B22-9F50-0E1B0E9B8408Q37094064-5524BF4B-6EC7-49E5-8ED5-AAB2A6140735
P2860
Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels
description
1973 nî lūn-bûn
@nan
1973 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1973 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
name
Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels
@ast
Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels
@en
Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels
@nl
type
label
Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels
@ast
Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels
@en
Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels
@nl
prefLabel
Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels
@ast
Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels
@en
Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels
@nl
P356
P1433
P1476
Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels
@en
P2093
P356
10.1136/BMJ.1.5844.13
P407
P577
1973-01-06T00:00:00Z